Commission Implementing Regulation (EU) 2024/1206 of 29 April 2024 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-decanol, 6-benzyladenine, aluminium sulfate, azadirachtin, bupirimate, dithianon, dodine, fluometuron, hexythiazox, isoxaben, lime sulphur, orange oil, prosulfuron, quinmerac, sintofen, sodium silver thiosulfate, tau-fluvalinate, tebufenozide, tembotrione and zinc phosphide

• CELEX: Implementing Regulation (EU) 2024/1206
• Articles: 3

Article 1

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX

ANNEX

I.

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

(1)

in the sixth column, expiration of approval, of row 311, quinmerac, the date is replaced by ‘31 December 2026’;

(2)

in the sixth column, expiration of approval, of row 314, zinc phosphide, the date is replaced by ‘31 December 2026’;

(3)

in the sixth column, expiration of approval, of row 317, 6-benzyladenine, the date is replaced by ‘15 July 2026’;

(4)

in the sixth column, expiration of approval, of row 323, dodine, the date is replaced by ‘15 July 2026’;

(5)

in the sixth column, expiration of approval, of row 328, tau-fluvalinate, the date is replaced by ‘31 January 2027’;

(6)

in the sixth column, expiration of approval, of row 330, bupirimate, the date is replaced by ‘31 January 2027’;

(7)

in the sixth column, expiration of approval, of row 333, 1-decanol, the date is replaced by ‘15 July 2026’;

(8)

in the sixth column, expiration of approval, of row 334, isoxaben, the date is replaced by ‘31 January 2027’;

(9)

in the sixth column, expiration of approval, of row 335, fluometuron, the date is replaced by ‘15 July 2026’;

(10)

in the sixth column, expiration of approval, of row 341, sintofen, the date is replaced by ‘15 July 2026’;

(11)

in the sixth column, expiration of approval, of row 343, azadirachtin, the date is replaced by ‘31 January 2027’;

(12)

in the sixth column, expiration of approval, of row 345, lime sulphur, the date is replaced by ‘31 January 2027’;

(13)

in the sixth column, expiration of approval, of row 346, aluminium sulfate, the date is replaced by ‘15 July 2026’;

(14)

in the sixth column, expiration of approval, of row 350, tebufenozide, the date is replaced by ‘31 January 2027’;

(15)

in the sixth column, expiration of approval, of row 351, dithianon, the date is replaced by ‘31 January 2027’;

(16)

in the sixth column, expiration of approval, of row 352, hexythiazox, the date is replaced by ‘31 January 2027’.

II.

In Part B of the Annex to Implementing Regulation (EU) No 540/2011, in the sixth column, expiration of approval, of row 56, orange oil, row 59, tembotrione and row 63, sodium silver thiosulfate, the date is replaced by ’31 December 2026’.

III.

In Part E of the Annex to Implementing Regulation (EU) No 540/2011, in the sixth column, expiration of approval, of row 6, prosulfuron, the date is replaced by ‘15 June 2026’.